Sign In
Buy BNTC
$11.71
-0.150 (-1.26%)
At Close: Jul 31, 2026
Benitec Biopharma Provides Update on BB-301 Tissue Transduction Study
12:00pm, Wednesday, 08'th Jul 2020
Benitec Biopharma, Inc. (NASDAQ: BNTC), a development-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on the proprietary DNA-directed RNA interference ("ddR
Wells and BMO cut views on Gilead in premarket analyst action
11:05am, Monday, 20'th Apr 2020
Benitec Biopharma Limited (NASDAQ:BNTC) initiated with Buy rating and $14 (140% upside) price target at Ladenburg Thalmann.AbbVie (NYSE:ABBV) upgraded to Outperform with a $93 (11% upside) price targe
Should You Be Concerned About Benitec Biopharma Limited's (NASDAQ:BNTC) Historical Volatility?
10:49am, Monday, 20'th Apr 2020
Anyone researching Benitec Biopharma Limited (NASDAQ:BNTC) might want to consider the historical volatility of the...
Weekly Summary Corporate dividends, name changes, new listings
07:30pm, Friday, 17'th Apr 2020
NEW YORK (AP) — Changes announced in corporate dividends Apr. 13-Apr. 17. INCREASED DIVIDENDS First Republic Bank .20 from .19 Johnson & Johnson 1.01 from .95 Procter & Gamble .7907 from .7459 REDUC
Dublin, April 17, 2020 -- The "Nucleic Acid Based Gene Therapy Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The.
Benitec Biopharma Announces the Completion of Redomiciliation to the United States
12:52pm, Wednesday, 15'th Apr 2020
Benitec Biopharma Inc. (NASDAQ: BNTC) is pleased to announce that the previously announced transaction to redomicile from Australia to the United States has been fully implemented today. The redomicil
Benitec Biopharma Appoints Edward Smith to the Board of Directors
01:28am, Wednesday, 15'th Apr 2020
Benitec Biopharma, Inc., a successor entity to Benitec Biopharma Limited (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today announce
Benitec Announces Supreme Court of Queensland Approval for Redomicile
02:09pm, Monday, 30'th Mar 2020
Benitec Biopharma Limited (Benitec or the "Company") (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announce that the Supreme Court of Queensland ("Court") has approved the scheme of arrangement to red
Benitec Announces Results of Scheme Meeting
01:44pm, Thursday, 26'th Mar 2020
Benitec Biopharma (ASX: BLT, NASDAQ: BNTC) ("Benitec" or the "Company"), a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLa
Is Benitec Biopharma (ASX:BLT) In A Good Position To Deliver On Growth Plans?
11:18pm, Thursday, 27'th Feb 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
US Stock Market Weekly Update February 10 - February 14, 2020
01:48pm, Sunday, 16'th Feb 2020
US Stock Market Weekly Update February 10 - February 14, 2020
Appendix 4C: Quarterly Cash Flow Report
01:08pm, Friday, 31'st Jan 2020
Benitec Biopharma (ASX: BLT, NASDAQ: BNTC) ("Benitec" or the "Company"), a biotechnology company developing novel genetic medicines via the proprietary DNA-directed RNA interference (ddRNAi) platform
ASX/NASDAQ ANNOUNCEMENT: Re-domiciliation to the United States
01:00pm, Wednesday, 27'th Nov 2019
Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) is pleased to announce its intention to redomicile from Australia to the United States of America. To implem
